Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

The company is reducing its workforce by 73% and evaluating strategic alternatives to preserve shareholder value.

Fintel reports that on January 10, 2025, Stifel downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to Hold ...

IGM Biosciences (IGMS) stock faces sharp selloff as the company abandons two therapeutic candidates, triggering Wall Street ...

Just two weeks into 2025, January is proving why it’s earned a reputation as the worst month for layoffs. | Just two weeks ...

IGM Biosciences has halted all oncology programs and faces a significant pipeline upheaval. Read why I maintain my Sell ...

We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...

JPMorgan upgraded IGM Biosciences (IGMS) to Neutral from Underweight without a price target The firm says that with the company announcing ...

After 20-plus years at AB, the firm’s co-heads of fixed-income and lead managers on this fund Gershon Distenfeld (credit) and Scott DiMaggio (rates) bring a ton of experience to the table.